Pharmaceutical Executive: October 2023

An Evolving ‘Opinion’ Landscape: New Paths—and Synergies—for Pharma KOLs & DOLs

October 13, 2023

Executive Roundtable

44

10

Industry experts discuss the relationship between digital and traditional (key) opinion leaders and how companies are adjusting their strategies to harness the unique brand engagement benefits each role can provide in driving better patient outcomes.

A Blueprint for Balance

October 13, 2023

Executive Profile

44

10

Stephen Rivera, vice president, global technical accounting advisory services and policy, Johnson & Johnson, capitalizes on his lively personality—and a courageous career journey—to bring people together to shape the future of biopharma.

Biopharma Stock Check: Market Review and Outlook

October 13, 2023

Feature

44

10

Exploring the pharma and biotech financing, M&A, and stock market pictures through the first half of 2023—and implications for the future, as market challenges continue to weigh heavily in senior management decision-making.

A Fond Farewell

October 08, 2023

From the Editor

44

10

It’s with a heavy heart that I share my departure from Pharmaceutical Executive.® It’s hard to believe that one year ago (in September 2022) I began my journey with the team here and the publication (and with all of you!). First and foremost, a huge thank you to you, the reader, for trusting me to share content with you.